US Stock MarketDetailed Quotes

TCBP TC BioPharm

Watchlist
  • 1.1400
  • -0.0200-1.72%
Close May 23 16:00 ET
  • 1.1800
  • +0.0400+3.51%
Pre 04:14 ET
5.64MMarket Cap-59P/E (TTM)

About TC BioPharm Company

TC Biopharm (Holdings) Plc is a clinical-stage biopharmaceutical company, which engages in the development of novel immunotherapy products based on its proprietary allogeneic gamma delta T cell platform. The company was founded by Michael Leek and Angela Scott in 2013 and is headquartered in Motherwell, the United Kingdom.

Company Profile

SymbolTCBP
Company NameTC BioPharm
Listing DateFeb 11, 2022
Issue Price4.24
Founded2013
CEOMr. Bryan Kobel
MarketNASDAQ
Employees41
Securities TypeDR
ADS Ratio1.0 : 20.0
Fiscal Year Ends12-31
AddressMaxim Park 1,2 Parklands Way,Holytown
CityMotherwell
ProvinceNK
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeML1 4WR
Phone44-141-433-7557

Company Executives

  • Name
  • Position
  • Salary
  • Bryan Kobel
  • Chief Executive Officer and Director
  • --
  • Martin Thorp
  • Chief Financial Officer and Director
  • --
  • Edward Niemczyk
  • Chairman of the Board
  • --
  • Dr. Mark Bonyhadi
  • Director
  • --
  • Anthony James Culverwell
  • Independent Director
  • --
  • Arlene M. Morris
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg